All News
Anti-inflammatory research
AVIDIN synthetized Mannich curcuminoids, C142 and C150 showed potent anti-inflammatory properties, Special focus on …
New patent granted in U.S.A.
Enantiomers of lead compounds for neurodegenerative diseases has been granted in the U.S.A. Avidin’s patent, entitled ‘Enantiomers of 8-Hydroxy Quinoline derivatives and the synthesis’ was
BIO2019 Convention in Philadelphia (PA)
Avidin’s CEO László Puskás and Head of International Relations Klára Kitajka are participating at BIO 2019 …
Alzheimer’s & Parkinson’s Diseases Congress-Lisbon
Poster in the 14th international conference on Alcheimer’s and Parkinson’s diseases and related neurological disorders
EUREKA Innovation Award for German-Hungarian collaborative program
In the last decade, oxidative stress has emerged as a key factor in many diseases including cardiovascular diseases, cancer, atherosclerosis, diabetes, arthritis, lung, kidney, liver disease, neurodegenerative disorders, and neuropathy.
Dénes Gábor Prize to Avidin’s CEO
AVIDIN’s CEO László Puskás was recently awarded with the Dénes Gábor Prize…
Competitiveness and Excellence Co-operations (VKE)
Genetic predisposition and life style management contribute to the development of type 2 diabetes mellitus (T2DM).
Our most advanced project’s lead optimization results published
Novel 8-hydroxyquinoline pharmacophore scaffold was synthetized by Avidin’s Medicinal Pharmacolgy department which has been shown to possess a range of activities as metal chelation, enzyme inhibition, cytotoxicity
Avidin organized the fifth TAT-CF general assembly held in Budapest.
The famous Géllert Hotel was the venue selected for meeting. Thursday 14th was dedicated to a workshop session where all the partners presented the most